EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), a former developer of eyecare, skin care and wound care products, announced that it will be changing its corporate name to Stablecoin Development Corporation, a rebrand that the company said reflects its strategic realignment as an on-chain holding company focused on protocol-aligned digital assets within the Sky protocol ecosystem, a decentralized finance platform.